These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 522699)

  • 1. The function of presynaptic dopamine receptors on noradrenergic nerve terminals.
    Korczyn AD
    Med Hypotheses; 1979 Oct; 5(10):1131-2. PubMed ID: 522699
    [No Abstract]   [Full Text] [Related]  

  • 2. Presynaptic regulation of the release of catecholamines.
    Langer SZ
    Pharmacol Rev; 1980 Dec; 32(4):337-62. PubMed ID: 6267618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Presynaptic receptors and modulation of neurotransmitter release].
    Langer SZ
    J Pharmacol; 1982; 13 Suppl 1():45-52. PubMed ID: 6125629
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of alpha-noradrenergic and Dopaminergic receptor systems depends on maturation of their presynaptic nerve terminals in the rat brain.
    Deskin R; Seidler FJ; Whitmore WL; Slotkin TA
    J Neurochem; 1981 May; 36(5):1683-90. PubMed ID: 6264034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presynaptic dopamine receptors in the cardiovascular system.
    Langer SZ; Vidal M; Duval N
    Clin Exp Hypertens A; 1987; 9(5-6):837-51. PubMed ID: 3621629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiology of the sympathetic nerve ending.
    Langer SZ; Hicks PE
    Br J Anaesth; 1984 Jul; 56(7):689-700. PubMed ID: 6145437
    [No Abstract]   [Full Text] [Related]  

  • 7. Acetylcholine, bretylium and release of norepinephrine from sympathetic nerve endings.
    Kopin IJ
    Ann N Y Acad Sci; 1967 Oct; 144(2):558-62. PubMed ID: 4295406
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurotransmitter release mechanisms in sympathetic and parasympathetic nerve terminals.
    Searl TJ; Cunnane TC
    Biochem Soc Trans; 1993 May; 21(2):416-20. PubMed ID: 8103006
    [No Abstract]   [Full Text] [Related]  

  • 9. Loss of noradrenergic and dopaminergic terminals in the chronically isolated cerebral cortex of the cat.
    Hirsch JC; Tassin JP; Thierry AM
    Br J Pharmacol; 1975 Mar; 53(3):455P-456P. PubMed ID: 1137754
    [No Abstract]   [Full Text] [Related]  

  • 10. Nonstriatal dopaminergic neurons: Section VIII. Autoreceptors and the function of dopaminergic terminals: Introduction: autoreceptors and the function of dopaminergic terminals.
    Bloom FE
    Adv Biochem Psychopharmacol; 1977; 16():429-31. PubMed ID: 18891
    [No Abstract]   [Full Text] [Related]  

  • 11. Somatostatin-induced activation and up-regulation of N-methyl-D-aspartate receptor function: mediation through calmodulin-dependent protein kinase II, phospholipase C, protein kinase C, and tyrosine kinase in hippocampal noradrenergic nerve endings.
    Pittaluga A; Feligioni M; Longordo F; Arvigo M; Raiteri M
    J Pharmacol Exp Ther; 2005 Apr; 313(1):242-9. PubMed ID: 15608072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the number of vesicles and the size of sympathetic nerve terminals following nerve stimulation.
    Côté MG; Palaïc D; Panisset JC
    Rev Can Biol; 1970 Jun; 29(2):111-4. PubMed ID: 5504295
    [No Abstract]   [Full Text] [Related]  

  • 13. Noradrenaline and sympathetic transmission.
    Whelan RF
    Med J Aust; 1968 Jan; 1(2):37-42. PubMed ID: 4295761
    [No Abstract]   [Full Text] [Related]  

  • 14. Intra-axonal transport and degeneration of adrenergic nerve terminals after axotomy with long and short nerve stump.
    Bareggi S; Dahlström A; Häggendal J
    Med Biol; 1974 Oct; 52(5):327-35. PubMed ID: 4372495
    [No Abstract]   [Full Text] [Related]  

  • 15. The interferance of muscarinic receptors with the noradrenaline release from sympathetic nerve endings caused by nicotinic agents.
    Lindmar R; Löffelholz K; Muscholl E
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 259(2):181-2. PubMed ID: 4232670
    [No Abstract]   [Full Text] [Related]  

  • 16. Adrenergic transmission at vasoconstrictor nerve terminals partially depleted of noradrenaline.
    Sedvall G; Thorson J
    Acta Physiol Scand; 1965 Jul; 64(3):251-8. PubMed ID: 5855022
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental demonstration of adrenergic fibers and their distribution in the cochlea].
    Holz E; Terayama Y
    Arch Klin Exp Ohren Nasen Kehlkopfheilkd; 1966; 187(2):592-5. PubMed ID: 5983284
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopamine: precursor or neurotransmitter in sympathetically innervated tissues?
    Bell C
    Blood Vessels; 1987; 24(5):234-9. PubMed ID: 3304474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic autoreceptors: background and implications.
    Carlsson A
    Adv Biochem Psychopharmacol; 1977; 16():439-41. PubMed ID: 560792
    [No Abstract]   [Full Text] [Related]  

  • 20. Organization of amygdaloid projections to brainstem dopaminergic, noradrenergic, and adrenergic cell groups in the rat.
    Wallace DM; Magnuson DJ; Gray TS
    Brain Res Bull; 1992 Mar; 28(3):447-54. PubMed ID: 1591601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.